Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07177482
NA
ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
Sponsor: Deling Li
View on ClinicalTrials.gov
Summary
This study aims to investigate 68Ga-MY6349, an immune-PET tracer targeting trophoblast cell surface antigen 2 (Trop2), for the noninvasive diagnosis of craniopharyngioma in vivo.
Key Details
Gender
All
Age Range
14 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-07-04
Completion Date
2026-12-31
Last Updated
2025-09-17
Healthy Volunteers
No
Conditions
Interventions
DIAGNOSTIC_TEST
68Ga-MY6349 PET/CT
Each subject receives a single intravenous injection of 68Ga-MY6349 and undergoes PET/CT imaging within the specified time.
Locations (1)
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China